临床试验/NCT00207597

NCT00207597已完成不适用

A Clinical Trial of Primary Prophylaxis Against Joint Disease in Children With Severe Hemophilia

Centers for Disease Control and Prevention0 个研究点目标入组 64 人开始时间: 1995年9月最近更新: 2005年9月21日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Centers for Disease Control and Prevention
入组人数: 64

研究概览研究设计入排标准研究者记录与标识符相似试验

研究概览

简要总结

This study examines the progression of joint disease in children with hemophilia assigned to either standard treatment or enhanced therapy.

研究设计

研究类型: Observational
观察模型: Natural History
时间视角: Prospective

入排标准

年龄范围: 1 Year 至 30 Months（Child）
性别: Male
接受健康志愿者: 否

入选标准

•Diagnosed with hemophilia A
•factor level less than 2%

排除标准

•More than 2 bleeds into the same joint

研究者

发起方

Centers for Disease Control and Prevention

申办方类型

Fed

相似试验

Extended Half-Life (EHL) Clotting Factor for Improving the Musculoskeletal Health of Patients With HemophiliaHaemophilia

NCT03914209Investigación en Hemofilia y Fisioterapia40

An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine EsperoctHaemophilia A

NCT05621746Novo Nordisk A/S100

Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment RegimensHemophilia A

NCT00927667Bayer156

Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric PatientsHemophilia A

NCT02727647Chulalongkorn University16

Outcomes of Prophylaxis and On-demand Treatment for Severe Hemophiliacs and Collection of Baseline Data in Hemophiliacs in TaiwanHemophilia

NCT02908243Taiwan Society of Thrombosis and Hemostasis350